Liao M - Search Results

1

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. Among authors: liao m. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

2

[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].

Liao ML, Chen ZW, Zheng Y, Wu CX, Lu S, Yu YF, Jian H, Cheng BJ. Liao ML, et al. Zhonghua Yi Xue Za Zhi. 2007 Jul 17;87(27):1876-80. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17923007 Chinese.

3

Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer.

Li ZM, Ding ZP, Luo QQ, Wu CX, Liao ML, Zhen Y, Chen ZW, Lu S. Li ZM, et al. Chest. 2013 Oct;144(4):1253-1260. doi: 10.1378/chest.13-0073. Chest. 2013. PMID: 23744276

4

A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.

Lu S, Li L, Luo Y, Zhang L, Wu G, Chen Z, Huang C, Guo S, Zhang Y, Song X, Yu Y, Zhou C, Li W, Liao M, Li B, Xu L, Chen P, Hu C, Hu C. Lu S, et al. Among authors: liao m. J Thorac Oncol. 2015 Jan;10(1):206-11. doi: 10.1097/JTO.0000000000000343. J Thorac Oncol. 2015. PMID: 25654728 Free article. Clinical Trial.

5

Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.

Niu X, Chen Z, Shen S, Liu Y, Zhou D, Zhang J, Li Z, Yu Y, Liao M, Lu S, He L. Niu X, et al. Among authors: liao m. J Thorac Oncol. 2010 May;5(5):658-66. doi: 10.1097/JTO.0b013e3181d5e447. J Thorac Oncol. 2010. PMID: 20234319 Free article.

6

[A comparative study between clinical response and pathologic changes to preoperative chemotherapy in non-small cell lung cancer].

Lu S, Liao M, Lin Z. Lu S, et al. Among authors: liao m. Zhonghua Zhong Liu Za Zhi. 1999 Sep;21(5):366-8. Zhonghua Zhong Liu Za Zhi. 1999. PMID: 11776576 Chinese.

7

Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.

Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ. Lu S, et al. Oncol Rep. 2008 Sep;20(3):581-7. Oncol Rep. 2008. PMID: 18695909

8

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.

Yang Y, Zhou Z, Niu XM, Li ZM, Chen ZW, Jian H, Ai XH, Cheng BJ, Liao ML, Lu S. Yang Y, et al. J Surg Oncol. 2012 Nov;106(6):736-41. doi: 10.1002/jso.23190. Epub 2012 Jun 18. J Surg Oncol. 2012. PMID: 22711667

9

Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.

Niu X, Liu F, Zhou Y, Zhou Z, Zhou D, Wang T, Li Z, Ye X, Yu Y, Weng X, Zhang H, Ye J, Liao M, Liu Y, Chen Z, Lu S. Niu X, et al. Among authors: liao m. Clin Cancer Res. 2017 Sep 1;23(17):5003-5014. doi: 10.1158/1078-0432.CCR-16-2688. Epub 2017 May 10. Clin Cancer Res. 2017. PMID: 28490462

10

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: liao m. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,818 results

Search Page

Filters